Zobrazeno 1 - 10
of 12
pro vyhledávání: '"R. M. HINDLEY"'
Publikováno v:
Journal of Lipid Research, Vol 19, Iss 1, Pp 3-11 (1978)
Investigation into the mechanism of action of BRL 10894 (ethyl 4-benzyloxybenzoate), a compound possessing hypolipidemic activity in the rat, disclosed participation in glycerolipid metabolism. In the presence of BRL 10894, an abnormal metabolite was
Externí odkaz:
https://doaj.org/article/f1bc2a6ed69243ed8f5de2c6400674aa
Autor:
P W, Young, D R, Buckle, B C, Cantello, H, Chapman, J C, Clapham, P J, Coyle, D, Haigh, R M, Hindley, J C, Holder, H, Kallender, A J, Latter, K W, Lawrie, D, Mossakowska, G J, Murphy, L, Roxbee Cox, S A, Smith
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 284(2)
A radioiodinated ligand, [125I]SB-236636 [(S)-(-)3-[4-[2-[N-(2-benzoxazolyl)-N-methylamino]ethoxy]3-[125I]i odo phenyl]2-ethoxy propanoic acid], which is specific for the gamma isoform of the peroxisomal proliferator activated receptor (PPARgamma), w
Autor:
P, Muzzin, O, Boss, N, Mathis, J P, Revelli, J P, Giacobino, K, Willcocks, G T, Badman, B C, Cantello, R M, Hindley, M A, Cawthorne
Publikováno v:
Molecular pharmacology. 46(2)
The RR-enantiomer of the beta 3-adrenergic receptor agonist BRL 37344 was tritiated to yield a high specific activity compound, [3H]SB 206606. This new, potentially specific, beta 3-adrenergic receptor ligand was characterized by binding studies usin
Publikováno v:
Journal of Lipid Research, Vol 19, Iss 1, Pp 3-11 (1978)
Investigation into the mechanism of action of BRL 10894 (ethyl 4-benzyloxybenzoate), a compound possessing hypolipidemic activity in the rat, disclosed participation in glycerolipid metabolism. In the presence of BRL 10894, an abnormal metabolite was
Publikováno v:
Chemischer Informationsdienst. 9
Publikováno v:
Chemischer Informationsdienst. 6
Publikováno v:
Chemischer Informationsdienst. 6
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 12(7)
1. When the novel hypolipidaemic compound 1-(4-carboxyphenoxy)-10-(4-chlorophenoxy) decane (CCD) was administered orally (250 mg/kg body weight for seven days) to rats, a lipophilic cholesterol-containing metabolite accumulated in the liver. 2. Analy
Autor:
Peter D. English, Keith H. Baggaley, R. M. Hindley, Joseph Green, Brian Morgan, Sandra D. Atkin
Publikováno v:
Biochemical Pharmacology. 24:1902-1903
Publikováno v:
Journal of the Chemical Society, Perkin Transactions 1. :1670
A convenient synthesis of 1-aryloxymethylimidazoles (1; X = O) from sodium imidazolide, dichloromethane or bromochloromethane, and sodium phenolates is described. 1-Aryloxymethyl- and 1-arylthiomethyl-imidazoles were also prepared by alkylation of im